Modern Diagnostic Ipo
Modern Diagnostic IPO Review & Key Points
Review: Neutral
Rating: 2
IPO Lead Managers aka Merchant Bankers
Beeline Capital Advisors Pvt. Ltd.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 2 | 3,200 | ₹2,88,000 |
| Retail Maximum | 2 | 3,200 | ₹2,88,000 |
| S-HNI Minimum | 3 | 4,800 | ₹4,32,000 |
| S-HNI Maximum | 6 | 9,600 | ₹8,64,000 |
| B-HNI Minimum | 7 | 11,200 | ₹10,08,000 |
| Investor Category | Share Offered | -% Shares |
| Anchor Investor | 11,61,600 Shares | 28.34% |
| QIB (Ex. Anchor) | 7,82,400 Shares | 19.09% |
| NII Shares Offered | 5,85,600 Shares | 14.29% |
| Retail Shares Offered | 13,63,200 Shares | 33.26% |
| Anchor Bidding Date | December 30, 2025 |
| Anchor Investors List | |
| Shares Offered | 11,61,600 Shares |
| Anchor Size | 10.45 Cr. |
| lock-in period end date 50% shares (30 Days) | February 4, 2026 |
| lock-in period end date 50% shares (90 Days) | April 5, 2026 |
| IPO Open Date: | December 31, 2025 |
| IPO Close Date: | January 2, 2026 |
| Basis of Allotment: | January 5, 2026 |
| Refunds: | January 6, 2026 |
| Credit to Demat Account: | January 6, 2026 |
| IPO Listing Date: | January 7, 2026 |
| IPO Bidding Cut-off Time: | January 2, 2026 – 5 PM |
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 1,10,00,000 | 99.99% |
| Promoter Holding Post Issue | 1,50,99,200 | 72.85% |
| Purpose | Crores |
| Funding capital expenditure for purchase of medical Equipments for diagnostic centre and laboratories | ₹20.69 |
| Funding Working Capital Requirement | ₹11.60 |
| Repayment of certain outstanding borrowings availed by the Company | ₹4.50 |
| General Corporate Purpose | ₹- |
| Period Ended | Revenue | Expense | PAT | Assets |
| 2023 | ₹56.61 | ₹62.55 | ₹5.73 | ₹36.54 |
| 2024 | ₹68.67 | ₹61.81 | ₹5.79 | ₹49.49 |
| 2025 | ₹78.80 | ₹66.08 | ₹8.97 | ₹64.57 |
| June 2025 | ₹22.67 | ₹18.40 | ₹3.00 | ₹77.86 |
| KPI | Values |
| ROE: | 55.21% |
| ROCE: | 36.18% |
| EBITDA Margin: | 23.04% |
| PAT Margin: | 11.51% |
| Debt to equity ratio: | 1.07 |
| Earning Per Share (EPS): | ₹8.15 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 43.27% |
| Net Asset Value (NAV): | ₹18.84 |
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Vijaya Diagnostic Centre Limited | 13.92 | 72.36 | 18.07% | 77.42 | – Cr. |
| IPO Open Date | December 31, 2025 |
| IPO Close Date | January 2, 2026 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹85 to ₹90 Per Share |
| Issue Size | Approx ₹37 Crores |
| Fresh Issue | Approx ₹37 Crores |
| Issue Type | Book Build Issue |
| IPO Listing | BSE SME |
| DRHP Draft Prospectus | |
| RHP Draft Prospectus |